Sorafenib with and without and propranolol and etodolac in patients with advanced hepatocellular carcinoma.
Phase of Trial: Phase II
Latest Information Update: 20 Jun 2014
Price : $35 *
At a glance
- Drugs Etodolac (Primary) ; Propranolol (Primary) ; Sorafenib (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- 20 Jun 2014 New trial record
- 03 Jun 2014 Results presented at the 50th Annual Meeting of the American Society of Clinical Oncology.